secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nexentis Technologies Inc. (NXTS)
CIK:        0001789192
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001493152-25-012130
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

N2OFF (NITO) provides $372K bridge loan to MitoCareX Bio pending acquisition
----------------------------------------------------------------------------

- Loan principal $372,000 from N2OFF to MitoCareX Bio Ltd., term 6 months, interest at Israel Tax Authority USD rate +3%.
- Disbursement in three tranches: $200K at signing, $86K on Sep 15, 2025, $86K on Oct 15, 2025.
- L.I.A. Pure Capital Ltd. guarantees full repayment of principal and interest.
- If acquisition closes, outstanding loan amount deducted from first-year allocation to MitoCareX.
- Loan supports MitoCareX's ongoing costs until acquisition stockholder approval and closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789192/000149315225012130/0001493152-25-012130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789192/000149315225012130/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer